Are We There Yet? 40 Years of Successes and Challenges for Children and Adolescents Living with HIV

Overview

Journal J Int AIDS Soc

Specialty Infectious Diseases

Date 2021 Jun 7

PMID 34097352

Citations 13

Authors

Rachel C Vreeman

Natella Y Rakhmanina

Winstone M Nyandiko

Thanyawee Puthanakit

Rami Kantor

Affiliations

Soon will be listed here.

Citing Articles

Stakeholder Perspectives on Research Consent and Reconsent for Procedures Involving Biological Samples and Biobanking of Children and Adolescents Living With HIV in Kenya.

Aluoch J, Chory A, Scanlon M, Gillette E, Koros H, Munyoro D J Int Assoc Provid AIDS Care. 2024; 23:23259582241305424.

PMID: 39668694 PMC: 11638995. DOI: 10.1177/23259582241305424.

Impact of HIV-Related Stigma on Antiretroviral Therapy Adherence, Engagement and Retention in HIV Care, and Transition to Adult HIV Care in Pediatric and Young Adult Populations Living With HIV: A Literature Review.

Perger T, Davtyan M, Foster C, Evangeli M, Berman C, Kacanek D AIDS Behav. 2024; 29(2):497-516.

PMID: 39453523 PMC: 11814060. DOI: 10.1007/s10461-024-04534-5.

"We did more than survive": lessons learned from studies of risk and resilience of young people growing up with HIV and mental health needs.

Poku O, Ahmed A, Liotta L, Kluisza L, Robbins R, Abrams E AIDS Care. 2024; 36(sup1):24-35.

PMID: 38446048 PMC: 11283975. DOI: 10.1080/09540121.2024.2308745.

Effects of economic interventions on pediatric and adolescent HIV care outcomes: a systematic review.

Bosma C, Toromo J, Ayers M, Foster E, McHenry M, Enane L AIDS Care. 2023; 36(1):1-16.

PMID: 37607246 PMC: 10843852. DOI: 10.1080/09540121.2023.2240071.

Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth.

Novitsky V, Nyandiko W, Vreeman R, Delong A, Howison M, Manne A Viruses. 2023; 15(7).

PMID: 37515104 PMC: 10383797. DOI: 10.3390/v15071416.

References

Boerma R, Boender T, Bussink A, Calis J, Bertagnolio S, Wit T . Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis. Clin Infect Dis. 2016; 63(12):1645-1654. DOI: 10.1093/cid/ciw645. View

Iyun V, Technau K, Vinikoor M, Yotebieng M, Vreeman R, Abuogi L . Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. Lancet HIV. 2021; 8(6):e353-e362. PMC: 8178242. DOI: 10.1016/S2352-3018(21)00004-7. View

Vreeman R, Rakhmanina N, Nyandiko W, Puthanakit T, Kantor R . Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV. J Int AIDS Soc. 2021; 24(6):e25759. PMC: 8183166. DOI: 10.1002/jia2.25759. View

Kacanek D, Malee K, Mellins C, Tassiopoulos K, Smith R, Grant M . Exposure to Violence and Virologic and Immunological Outcomes Among Youth With Perinatal HIV in the Pediatric HIV/AIDS Cohort Study. J Adolesc Health. 2016; 59(1):30-7. PMC: 4920719. DOI: 10.1016/j.jadohealth.2016.03.004. View

Vreeman R, McCoy B, Lee S . Mental health challenges among adolescents living with HIV. J Int AIDS Soc. 2017; 20(Suppl 3):21497. PMC: 5577712. DOI: 10.7448/IAS.20.4.21497. View

. Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. J Int AIDS Soc. 2020; 23(4):e25477. PMC: 7160415. DOI: 10.1002/jia2.25477. View

Koay W, Kose-Otieno J, Rakhmanina N . HIV Drug Resistance in Children and Adolescents: Always a Challenge?. Curr Epidemiol Rep. 2021; 8(3):97-107. PMC: 7971393. DOI: 10.1007/s40471-021-00268-3. View

Penazzato M, Gnanashanmugam D, Rojo P, Lallemant M, Lewis L, Rocchi F . Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations. Clin Infect Dis. 2017; 64(11):1597-1603. PMC: 5927327. DOI: 10.1093/cid/cix194. View

Okonji E, Mukumbang F, Orth Z, Vickerman-Delport S, van Wyk B . Psychosocial support interventions for improved adherence and retention in ART care for young people living with HIV (10-24 years): a scoping review. BMC Public Health. 2020; 20(1):1841. PMC: 7708133. DOI: 10.1186/s12889-020-09717-y. View

10.

Ritchwood T, Malo V, Jones C, Metzger I, Atujuna M, Marcus R . Healthcare retention and clinical outcomes among adolescents living with HIV after transition from pediatric to adult care: a systematic review. BMC Public Health. 2020; 20(1):1195. PMC: 7398377. DOI: 10.1186/s12889-020-09312-1. View

11.

Moore C, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo C . ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based.... BMC Infect Dis. 2021; 21(1):5. PMC: 7809782. DOI: 10.1186/s12879-020-05672-6. View

12.

Inzaule S, Ondoa P, Peter T, Mugyenyi P, Stevens W, Wit T . Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa. Lancet Infect Dis. 2016; 16(11):e267-e275. DOI: 10.1016/S1473-3099(16)30118-9. View

13.

Vreeman R, Scanlon M, Tu W, Slaven J, McAteer C, Aluoch J . Validation of an HIV/AIDS Stigma Measure for Children Living with HIV and Their Families. J Int Assoc Provid AIDS Care. 2019; 18:2325958219880570. PMC: 6900619. DOI: 10.1177/2325958219880570. View

14.

. Unexplained immunodeficiency and opportunistic infections in infants--New York, New Jersey, California. MMWR Morb Mortal Wkly Rep. 1982; 31(49):665-7. View

15.

Sirikum C, Sophonphan J, Chuanjaroen T, Lakonphon S, Srimuan A, Chusut P . HIV disclosure and its effect on treatment outcomes in perinatal HIV-infected Thai children. AIDS Care. 2014; 26(9):1144-9. DOI: 10.1080/09540121.2014.894614. View